Franklin Resources
AVIR icon

Franklin Resources’s Atea Pharmaceuticals AVIR Stock Holding History

Franklin Resources’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-56,460
Closed -$211K – 2670
2023
Q2 		$211K Buy
+56,460
New +$211K ﹤0.01% 2356
2022
Q2 		– Sell
-23,139
Closed -$167K – 2371
2022
Q1 		$167K Hold
23,139
– – ﹤0.01% 2201
2021
Q4 		$207K Sell
23,139
-28,660
-55% -$447K ﹤0.01% 2229
2021
Q3 		$1.82M Buy
+51,799
New +$1.44M ﹤0.01% 1479

Other funds holding AVIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources's AVIR Position: Q3 2023 in Review

Franklin Resources sold out of Atea Pharmaceuticals (AVIR) in Q3 2023, closing a stake of 56,460 shares — an estimated $211K sold.

Franklin Resources first reported a position in AVIR in Q3 2021 and held it in 4 quarters. The position peaked at $1.82M in Q3 2021. 119 funds tracked by Wall St. Rank hold AVIR as of Q3 2023.

  • Franklin Resources reported no remaining Atea Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Franklin Resources sold 56,460 Atea Pharmaceuticals shares in Q3 2023, an estimated $211K.
  • Franklin Resources first reported a position in Atea Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • Franklin Resources's Atea Pharmaceuticals position peaked at $1.82M in Q3 2021.
  • 119 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2023.

Based on Franklin Resources's 13F filing for Q3 2023, filed 13 Nov 2023.